CCR2 and pancreatic neoplasm: Experimental evidence found that pancreatic cancer cell-derived exosomes enriched with GOT1 inhibited cellular ferroptosis to promoted pancreatic cancer cell progression through mechanisms like upregulating CCR2 expression and activating the Nrf1/HO2559-1 pathway (80).